Cryo-Cell International Q2 EPS $0.07 Up From $0.04 YoY, Sales $7.800M Down From $7.900M YoY
Cryo-Cell International | 10-Q: Quarterly report
Press Release: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
Express News | Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
Stem Cell Banking Market Surges to USD 28.9 Billion by 2033, Propelled by 12.4% CAGR - Verified Market Reports
12 Health Care Stocks Moving In Friday's Intraday Session
Express News | Amex Halt Add Info Lst 3.840000
12 Health Care Stocks Moving In Thursday's After-Market Session
Cryo-Cell Plan Accepted to Regain NYSE Compliance
Cryo-Cell International Receives Renewed FACT Accreditation For Cord Blood Collection, Banking And Release For Administration Donations; Re-Accreditation Extends Through April 3, 2029
Express News | Amex Halt Add Info Lst 3.420000
Wall Street Analysts Are Neutral on Top Healthcare Picks
Cryo-Cell International Faces NYSE American Compliance Review and Potential Delisting Risk Ahead of 2027 Deadline
Cryo-Cell International Q1 EPS $0.01 Beats $(0.10) Estimate, Sales $7.683M Beat $7.631M Estimate
Cryo-Cell International | 10-Q: Q1 2026 Earnings Report
Express News | Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
Press Release: Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
Cryo-Cell Faces NYSE American Listing Compliance Challenges
Express News | Cryo-Cell Receives NYSE American Continued Listing Notice
Maxim Group Maintains Cryo-Cell International(CCEL.US) With Hold Rating